Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 25,146 | 57,405 | 16,116 | 60,077 | 34,678 |
| Cost of Goods | 364 | 1,377 | 1,940 | 895 | 137 |
| Gross Profit | 24,782 | 56,028 | 14,176 | 59,182 | 34,541 |
| Operating Expenses | 64,665 | 105,567 | 131,782 | 146,310 | 76,204 |
| Operating Income | -39,519 | -49,162 | -116,666 | -86,233 | -41,526 |
| Interest Expense | 1,872 | 2,614 | 2,104 | 1,947 | 1,026 |
| Other Income | 560 | -1,177 | -1,993 | -6,049 | -998 |
| Pre-tax Income | -40,831 | -52,953 | -120,763 | -94,229 | -43,550 |
| Net Income Continuous | -40,831 | -52,953 | -120,763 | -94,229 | -43,550 |
| Minority Interests | -161 | -944 | -1,341 | -862 | -807 |
| Net Income | $-40,670 | $-52,009 | $-119,422 | $-93,367 | $-42,743 |
| EPS Basic Total Ops | -1.24 | -1.86 | -6.51 | -6.46 | -4.30 |
| EPS Basic Continuous Ops | -1.12 | -1.89 | -6.41 | -6.34 | -3.81 |
| EPS Diluted Total Ops | -1.24 | -1.86 | -6.51 | -6.46 | -4.30 |
| EPS Diluted Continuous Ops | -1.12 | -1.89 | -6.41 | -6.34 | -3.81 |
| EPS Diluted Before Non-Recurring Items | -1.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-38,802 | $-48,331 | $-115,676 | $-85,133 | $-39,956 |